Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents

2004 ◽  
Vol 145 (4) ◽  
pp. 445-451 ◽  
Author(s):  
Elizabeth Goodman ◽  
Stephen R. Daniels ◽  
John A. Morrison ◽  
Bin Huang ◽  
Lawrence M. Dolan
Keyword(s):  
Metabolic Syndrome ◽  
World Health Organization ◽  
Education Program ◽  
National Cholesterol Education Program ◽  
World Health ◽  
Adult Treatment ◽  
Adult Treatment Panel ◽  
The World ◽  
Health Organization

scholarly journals Metabolic syndrome and schizophrenia

2005 ◽  
Vol 186 (6) ◽  
pp. 455-456 ◽  
Author(s):  
Jogin H. Thakore
Keyword(s):  
Metabolic Syndrome ◽  
World Health Organization ◽  
Education Program ◽  
National Cholesterol Education Program ◽  
Reference Population ◽  
World Health ◽  
Adult Treatment Panel ◽  
The World ◽  
Health Organization

Metabolic syndrome – a cluster of disorders comprising obesity (central and abdominal), dyslipidaemias, glucose intolerance, insulin resistance (or hyperinsulinaemia) and hypertension – is highly predictive of type 2 diabetes mellitus and cardiovascular disease. In order to improve detection of this syndrome and estimate its prevalence, both the World Health Organization (Alberti & Zimmet, 1998) and the National Cholesterol Education Program Adult Treatment Panel (National Cholesterol Education Program, 2001) have provided working criteria for its diagnosis (the World Health Organization criteria are reproduced in an appendix to this paper; copyright restrictions prevent the inclusion here of the National Cholesterol Education Program criteria). Using the latter criteria, Heiskanen et al (2003) found that the frequency of metabolic syndrome was 2–4 times higher in a group of people with schizophrenia, treated with both atypical and typical neuroleptics, than in an appropriate reference population.

Sign in / Sign up

Export Citation Format

Share Document